Related Experiment Video
Updated: Jul 29, 2025

A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery
Published on: January 18, 2018
Early Interventional Treatments for Patients with Cancer Pain: A Narrative Review
Uri Hochberg1, Pablo Ingelmo2,3,4, Ester Solé5
1Pain Institute of the Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Interventional pain management offers a "fourth step" for cancer pain refractory to standard treatments. Early application of these advanced techniques can improve quality of life and reduce opioid use.
Area of Science:
- Oncology
- Pain Management
- Interventional Radiology
Background:
- 10-20% of cancer patients experience pain inadequately controlled by WHO's three-step ladder.
- Refractory cancer pain necessitates advanced treatment strategies beyond conventional analgesics.
Purpose of the Study:
- To review evidence on interventional treatments for refractory cancer pain.
- To compare the efficacy and outcomes of early versus late indications for these procedures.
Main Methods:
- Systematic search for studies on interventional techniques for cancer pain.
- Narrative review and analysis of available evidence, focusing on timing of intervention.
Main Results:
- Strong evidence supports the efficacy of procedures like neurolysis, vertebroplasty, kyphoplasty, and intrathecal drug delivery.
- These interventions decrease symptom burden, reduce opioid consumption, and improve quality of life.
- Evidence comparing early versus late intervention timing is scarce and of low quality.
Conclusions:
- Interventional techniques are effective for refractory cancer pain and may positively impact survival.
- Early consideration of interventional options is suggested, rather than reserving them as a last resort.
- Further high-quality research is needed to guide optimal timing for interventional cancer pain management.
More Related Videos
Related Concept Videos
Analgesia and Pain Management
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Peripheral Artery Disease V: Postoperative Nursing Management
Treatment Resistant Cancers

